Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge

Table 6

Subgroup analyses for gender and organ rejection.

		Yes	No	Total
Male	Group 1	1	5	6	0.301	—
	Group 2	4	4	8
	Total	5	9	14
	Group 2	4	4	8	1.000	0.000
	Group 3	15	19	34
	Total	19	23	42
Female	Group 1	2	5	7	1.000	—
	Group 2	0	1	1
	Total	2	6	8
	Group 2	0	1	1	1.000	—
	Group 3	5	5	10
	Total	5	6	11
Total	Group 1	3	10	13	0.376	—
	Group 2	4	5	9
	Total	7	15	22
	Group 2	4	5	9	1.000	0.000
	Group 3	20	24	44
	Total	24	29	53